Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females

Gene

Volumn 560, Issue 1, 2015, Pages 77-82

  Shaker, Olfat ^a   Maher, Moataz ^a   Nassar, Yasser ^a   Morcos, George ^a   Gad, Ziad ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Breast cancer; Metastasis; MiR 155; MiR 197; MiR 205; MiR 29b 2

Indexed keywords

MICRORNA; MICRORNA 155; MICRORNA 197; MICRORNA 205; MICRORNA 92B 2; TUMOR MARKER; UNCLASSIFIED DRUG; MIRN155 MICRORNA, HUMAN; MIRN197 MICRORNA, HUMAN; MIRN205 MICRORNA, HUMAN; MIRN29 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BONE METASTASIS; BREAST CANCER; BREAST METASTASIS; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE EXPRESSION; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; BLOOD; BREAST NEOPLASMS; CASE CONTROL STUDY; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84923069688     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.01.062     Document Type: Article

References (44)

1. Abd-El-Fattah A., Sadik N., Shaker O., et al. Differential micro-RNAs expression in serum of patients with lung cancer, pulmonary tuberculosis and pneumonia. Cell Biochem. Biophys. 2013, 67(3):875-884.
2. Benson J.R., Jatoi I., Keisch M., et al. Early breast cancer. Lancet 2009, 373:1463-1479.
3. Bentwich I., Avniel A., Karov Y., et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 2005, 37(7):766-770.
4. Bushati N., Cohen S.M. MicroRNA functions. Annu. Rev. Cell Dev. Biol. 2007, 23:175-205.
5. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6(11):857-866.
6. Chang T.C., Yu D., Lee Y.S., et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 2008, 40:43-50.
7. Chen K., Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. 2007, 8(2):93-103.
8. Cho W.C. OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer 2007, 6:60-66.
9. Dai W., Wang C., Wang F., et al. Anti-miR-197 inhibits migration in HCC cells by targeting KAI 1/CD82. Biochem. Biophys. Res. Commun. 2014, 446(2):541-548. (4).
10. El-Bolkainy M.N. Topographic Pathology of Cancer 2000, National Cancer Institute (NCI), Cairo University. 2nd edition.
11. Elgamal O.A., Park J.K., Gusev Y., et al. Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation. PLoS One 2013, 8(10):e76402.
12. Fabbri M., Garzon R., Cimmino A., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(40):15805-15810.
13. Faraoni I., Antonetti F.R., Cardone J., et al. miR-155 gene: a typical multifunctional microRNA. Biochim. Biophys. Acta 2009, 1792(6):497-505.
14. Gregory P.A., Bert A.G., Paterson E.L., et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10(5):593-601.
15. Hamada S., Satoh K., Miura S., et al. miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. J. Cell. Physiol. 2013, 228(6):1255-1263.
16. Iorio M.V., Ferracin M., Liu C.G., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65:7065-7070.
17. Iorio M.V., Casalini P., Piovan C., et al. microRNA-205 regulates HER3 in human breast cancer. Cancer Res. 2009, 69:2195-2200.
18. Kren B.T., Wong P.Y., Sarver A., et al. MicroRNAs identified in highly purified liver-derived mitochondria may play a role in apoptosis. RNA Biol. 2009, 6(1):65-72.
19. Lang N., Liu M., Tang Q.L., et al. Effects of microRNA-29 family members on proliferation and invasion of gastric cancer cell lines. Chin. J. Cancer 2010, 29(6):603-610.
20. Lehmann U., Streichert T., Otto B., et al. Identification of differentially expressed microRNAs in human male breast cancer. BMC Cancer 2010, 10:109-115. (23).
21. Liqin Du., Jeoffrey J., Maria C., et al. miR-93, miR-98 and miR-197 regulate expression of tumor suppressor gene FUS1. Mol. Cancer Res. 2009, 7(8):1234-1243.
22. Markou A., Tsaroucha E.G., Kaklamanis L., et al. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin. Chem. 2008, 54:1696-1704.
23. Mattiske S., Suetani R.J., Neilsen P.M., et al. The oncogenic role of miR-155 in breast cancer. Cancer Epidemiol. Biomarkers Prev. 2012, 21:1236-1239.
24. Mercatelli N., Beldiman C., Brouard T., et al. Mir-205 modulates acinar size and morphology of transformed breast epithelial cells. OncomiRs 2012, 1:2-9.
25. Mitchell P.S., Parkin R.K., Kroh E.M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10513-10518.
26. Mott J.L., Kobayashi S., Bronk S.F., et al. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007, 26(42):6133-61340.
27. Pekarsky Y., Santanam U., Cimmino A., et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 2006, 66(24):11590-11593.
28. Pereira P.M., Marques J.P., Soares A.R., et al. MicroRNA expression variability in human cervical tissues. PLoS One 2010, 5(7):e11780.
29. Poudyal D., Cui X., Le P.M., et al. A key role of microRNA-29b for the suppression of colon cancer cell migration by American ginseng. PLoS One 2013, 8(10):e75034.
30. Sanduja S., Blanco F.F., Dixon D.A. The roles of TTP and BRF proteins in regulated mRNA decay. Wiley Interdiscip. Rev. RNA 2011, 2(1):42-57.
31. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62:10-29.
32. Sonkoly E., Janson P., Majuri M.L., et al. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J. Allergy Clin. Immunol. 2010, 126(3):581-589.
33. Stewart B.W., Kleihues P. World Cancer Report 2003, International Agency for Research on Cancer (IARC), (351 pages).
34. SuYing Z., Qian W., Fen G., et al. MiR-155 may be useful as a blood-based biomarker for breast cancer screening. Chin. Sci. Bull. 2012, 57:3466-3468.
35. Wang C., Bian Z., Wei D., Zhang J. miR-29b regulates migration of human breast cancer cells. Mol. Cell. Biochem. 2011, 352(1-2):197-207.
36. Wang Y., Zhang X., Li H., et al. The role of miRNA-29 family in cancer. Eur. J. Cell Biol. 2013, 92(3):123-128.
37. Weber F., Teresi R.E., Broelsch C.E., et al. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J. Clin. Endocrinol. Metab. 2006, 91(9):3584-3591.
38. Wu W., Lin Z., Zhuang Z., et al. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur. J. Cancer Prev. 2009, 18:50-55.
39. Wu H., Zhu S., Mo Y. Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res. 2009, 19:439-448.
40. Wu Hailong, Zhu Shoumin, Mo Yin-Yuan Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res. 2009, 19(4):439-448.
41. Wu Z., Huang X., Huang X., et al. The inhibitory role of Mir-29 in growth of breast cancer cells. J. Exp. Clin. Cancer Res. 2013, 32:98-103. (1).
42. Xu L., Xu Y., Jing Z., et al. Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia. Exp. Hematol. Oncol. 2014, 3(17):1-7.
43. Zhang C., Zhao J., Deng H.Y. MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1. J. Biomed. Sci. 2013, 20:79-83.
44. Zhu W.Z., Qin W.Y., Atasoy U., et al. Circulating microRNAs in breast cancer and healthy subjects. BMC Res. Notes 2009, 2:89-94.